��������

DAMMAM: The first Mitsubishi Power J-series air-cooled gas turbine to be assembled in �������� was launched by Prince Saud bin Bandar bin Abdulaziz, deputy governor of the Eastern Province, on Thursday in Dammam.

Prince Saud said it marked an important step in advancing the Kingdom’s industrial capabilities and localization goals, highlighting the role of local talent and international expertise in achieving Vision 2030 targets.

Adel Al-Juraid, president of Mitsubishi ��������, said the turbine launch coincided with Mitsubishi Power’s 60th anniversary in the Kingdom, underlining the company’s long-term commitment to the country’s industrial growth, energy security and sustainability.

He added the Dammam facility’s growing capabilities would help position �������� as a regional hub for advanced power generation solutions.

The newly assembled M501JAC turbine was installed at the 475 MW Admiral cogeneration plant in Jubail, supplying power and steam to Saudi Aramco’s SATORP complex which includes one of the region’s largest steam crackers.

Mitsubishi Power’s president and CEO, Takao Tsukui, said the project supported ��������’s energy transformation and emissions reduction goals and reflected the company’s mission of empowering Saudi talent.

Tsukui added the Dammam facility’s success stemmed from Mitsubishi Power’s National Program, which provides technical training and exchange opportunities for Saudi employees, who now make up more than half of the company’s workforce in the Kingdom.

RIYADH: ��������’s healthcare sector is set for another round of strategic expansion, with new biotechnology and pharmaceutical partnerships expected to be unveiled at the Global Health Exhibition 2025 in Riyadh later this month.

Held with the support of the Ministry of Health, the eighth edition of the event will run from Oct. 27-30.

The event will serve as a platform for the Kingdom to attract investment and accelerate progress toward the goals of Vision 2030 to improve healthcare quality and boost the sector’s contribution to the economy.

The value of ��������’s healthcare industry is projected to rise from SR199 billion ($53 billion) in 2020 to SR318 billion by 2030, with the private sector’s contribution expected to double to SR145 billion.

The ministry said it was working to create a more competitive investment environment, simplify regulatory processes, and support innovation across fields including biotechnology, vaccine production, pharmaceuticals, health tourism, and digital health solutions.

These areas are seen as central to positioning the Kingdom as a regional and global hub for healthcare innovation and manufacturing.

Last year’s Global Health Exhibition generated investments of more than SR50 billion, including major deals such as the SR4 billion drug manufacturing partnership between NUPCO, Novo Nordisk, and Sanofi; the SR5 billion expansion plan by Fakeeh Care Group; and acquisition agreements worth over SR4 billion by Dallah Healthcare.

The ministry said this year’s edition would build on that momentum, with new agreements expected in biotech, advanced medical technologies, artificial intelligence, and digital health, further supporting the Kingdom’s drive toward self-sufficiency and an innovation-led healthcare ecosystem.